Related by context. Frequent words. (Click for all words.) 76 Clinical Trial Results 75 Pulmonary Arterial Hypertension 75 Chronic Heart Failure 74 Metastatic Melanoma 74 Benign Prostatic Hyperplasia 74 Venous Thromboembolism 74 Atopic Dermatitis 73 Combination Therapy 73 Bladder Cancer 73 Drug Resistant 73 Phase III Clinical Trial 73 Chronic Hepatitis C 73 Metastatic Colorectal Cancer 73 Drug Candidate 73 Chronic Lymphocytic Leukemia 72 Hepatitis C Virus 72 Elderly Patients 72 Overactive Bladder 72 Liver Cancer 72 Cancer Treatments 72 Allergic Rhinitis 71 Autoimmune Diseases 71 Prostate Cancer Patients 71 Patients Treated 70 Meta Analysis 70 Solid Tumors 70 Smallpox Vaccine 70 Ischemic 70 Prostate Cancer Treatment 70 Postmenopausal Women 70 Systematic Review 70 Phase III Trial 70 Preclinical Data 70 Pivotal Phase III 70 Advanced Prostate Cancer 70 Breast Cancer Treatment 70 Monoclonal Antibodies 70 Glioma 70 Pivotal Trial 70 Diabetic Patients 69 Heart Failure Patients 69 Patient Enrollment 69 Monoclonal Antibody 69 Cardiovascular Events 69 RNAi Therapeutics 69 Systemic Lupus Erythematosus 69 Acute Myocardial Infarction 69 Insulin Resistance 69 Small Molecule 69 Immunogenicity 69 Malaria Vaccine 69 Pirfenidone 69 Carcinoma 69 Esophageal Cancer 69 Urinary Incontinence 69 Early Diagnosis 69 Influenza Vaccine 69 Inhibits 69 Alemtuzumab 68 Natalizumab 68 Diabetic Macular Edema 68 Thyroid Cancer 68 Pivotal Phase 68 Peripheral Artery Disease 68 Capecitabine 68 Monotherapy 68 Trastuzumab 68 Dyslipidemia 67 Aliskiren 67 Erlotinib 67 Targeted Therapy 67 Epratuzumab 67 Dasatinib 67 Randomized Controlled Trial 67 Bortezomib 67 Irinotecan 67 Well Tolerated 67 Low Dose 67 Prophylaxis 67 Metastatic 67 Breast Cancer Patients 67 Completes Enrollment 66 Peripheral Arterial Disease 66 Cancer Vaccine 66 Bevacizumab 66 Pulmonary Hypertension 66 Cancer Immunotherapy 66 Clinical Study 66 Gaucher Disease 66 Hormone Therapy 66 Brain Tumors 66 FDA Accepts 66 Tolerability 66 Lenalidomide 66 Cancer Therapies 66 Microspheres 66 Hepatic 66 Metastatic Breast Cancer 66 Tesetaxel 66 Drug Pipeline 65 Increased Risk